Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
Fierce Pharma
Pfizer's chief strategist Andrew Baum to step down: reports
Pfizer's chief strategy and innovation officer Andrew Baum is stepping down merely two years into the role, according to reports.
Zoey Becker
Apr 21, 2026 11:24am
Biotech’s top 5 stock picks for 2026: analyst
Dec 23, 2025 10:05am
Bicara CEO: ASCO data resonate more with 'people that matter'
Jun 2, 2025 4:26pm
CROs should brace for continued slow Big Pharma demand: analyst
Jan 28, 2025 3:45pm
CRO and clinical trial markets set for growth by 2030: reports
Dec 4, 2024 3:15pm
In first, autoimmune patients respond to allogeneic CAR-T cells
Jul 17, 2024 3:26pm
